Clinical trial for Auditory Verbal Hallucinations
Official title Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
ClinicalTrials.gov ID: NCT07902518
What this study is testing
- What it's testing
- The study wants to see if theta‑burst transcranial magnetic stimulation can lower the severity of auditory hallucinations and improve other symptoms, and to check safety and side effects.
- Who it's for
- Adults with schizophrenia, schizoaffective or other psychotic disorders who still hear voices despite taking antipsychotic medication.
- What's involved
- Participants will have an initial health assessment, then receive 20 sessions of active theta‑burst brain stimulation over two weeks (two sessions each weekday), followed by follow‑up visits to assess symptoms and side effects.
- Time commitment
- The trial lasts about six weeks, with daily treatment visits for two weeks and follow‑up visits about one week and one month after the last session.
- Time commitment: about 10 weeks
You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older.
- Diagnosis of a schizophrenia-spectrum disorder or bipolar disorder with psychotic symptoms.
- Presence of persistent auditory verbal hallucinations with persecutory content.
- Auditory verbal hallucinations s that have not responded to ≥2 antipsychotic trials, each lasting more than 6 weeks, with daily...
- Stable pharmacological treatment for at least two months before enrollment.
You likely can't join if
- History of epilepsy or seizures.
- Neurological disorders that may interfere with the study or increase the risks associated with transcranial magnetic stimulation.
- Substance use disorder within the previous six months.
- Electroconvulsive therapy (ECT) within the previous six months.
- Any other contraindication to transcranial magnetic stimulation.
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.